A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)

Efficacy and Safety of Avatrombopag vs. Avatrombopag Combined With rhTPO in the Treatment of SAA

NCT06254287 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Observational Study of Fostamatinib as Second Line Therapy in Adult Patients With Immune Thrombocytopenia (ITP) and Insufficient Response to a Prior Therapy

NCT04904276 ·Status: TERMINATED

An Observational Study to Evaluate the Efficacy of Biweekly Romiplostim in Adult Patients With ITP

NCT02338414 ·Status: UNKNOWN ·Phase: PHASE2

Avatrombopag for Platelet Recovery Post-UCBT in Patients With Bone Marrow Failure Disease

NCT05823376 ·Status: RECRUITING

A Multicenter Prospective Study of Iptacopan in the Treatment of Refractory/Relapsed Autoimmune Hemolytic Anemia (AIHA)

NCT06847607 ·Status: NOT_YET_RECRUITING ·Phase: NA

Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272)

NCT03123588 ·Status: TERMINATED ·Phase: PHASE2

The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS)

NCT01566695 ·Status: COMPLETED ·Phase: PHASE3

Study of Romiplostim(AMG531) in Subjects With Aplastic Anemia

NCT02773290 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Romiplostim N01 Combined With Glucocorticoids as the First-line Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Interventional Trial

NCT06992128 ·Status: RECRUITING ·Phase: PHASE2

Romiplostim N01 for Platelet Recovery in Adult Hematologic Malignancies Patients Undergoing UCBT

NCT06693791 ·Status: RECRUITING ·Phase: PHASE2

Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 Months

NCT04516967 ·Status: COMPLETED ·Phase: PHASE3

A Study of Romiplostim N01 Plus IST vs. Placebo Plus IST for Treatment-Naive Severe Aplastic Anemia

NCT07345000 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Efficacy and Safety of Thrombopoietin In Patients With Severe and Very Severe Aplastic Anemia

NCT02857530 ·Status: UNKNOWN ·Phase: PHASE2

Hetrombopag or Placebo in Treatment-Naive Severe Aplastic Anemia

NCT03825744 ·Status: COMPLETED ·Phase: PHASE3

Open-Label Study to Evaluate the Safety and Efficacy of Avatrombopag and Remission Rates in Adults With ITP of ≤6 Months

NCT05046327 ·Status: WITHDRAWN ·Phase: PHASE3

The Combination of Atorvastatin, Acetylcysteine and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

NCT03460808 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Once-Daily Oral Avatrombopag Tablets Used in Subjects With Chronic Liver Diseases and Thrombocytopenia Prior to Elective Surgical or Diagnostic Procedures

NCT00914927 ·Status: COMPLETED ·Phase: PHASE2

Inaticabtagene Autoleucel Injection in the Treatment of Autoimmune Hemolytic Anemia After Three or More Lines of Therapy

NCT07091370 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Evaluating the Pharmacokinetics and Pharmacodynamics of Romiplostim in Patients With Immune Thrombocytopenia (ITP)

NCT02868060 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

The Combination of Terbutaline and Danazol as the Treatment of Corticosteroid-resistant/Relapse Immune Thrombocytopenia

NCT05494307 ·Status: UNKNOWN ·Phase: PHASE2

The Phase III Clinical Study of Herombopag for the Treatment of Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive Surgery

NCT06507436 ·Status: RECRUITING ·Phase: PHASE3

Romiplostim Plus Dexamethasone vs Dexamethasone in Patients With Newly Diagnosed Primary Immune Thrombocytopenia

NCT05325593 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

The Tolerability，Safety，PK/PD Study of rhTPO in the Patients With Liver Function Impairment

NCT03673215 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab

NCT07039422 ·Status: RECRUITING ·Phase: PHASE2

An Observational, Multicenter Study to Evaluate the Safety and Effectiveness of Hetrombopag in Patients With ITP or AA

NCT05333861 ·Status: NOT_YET_RECRUITING